Universal reference book for medicines
Product name: FALIMINT ® (FALIMINT ® )

Active substance: acetylaminonitropropoxybenzene

Type: Preparation with weak local anesthetic and analgesic action for topical application in ENT practice and dentistry

Manufacturer: BERLIN-PHARMA (Russia) manufactured by BERLIN-CHEMIE (Germany)
Composition, form of production and packaging
?
Dragee almost white, round, biconvex, with a smooth surface, uniform in color.
1 dragee

acetylaminonitropropoxybenzene 25 mg

Excipients: sucrose, gelatin, solid fat, talc, copovidone, silicon dioxide colloid, magnesium stearate.

Sheath composition: sucrose, talc, glucose syrup, simethicone emulsion 30%, paraffin liquid, paraffin hard.

20 pcs.
- blisters (1) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2014.

PHARMACHOLOGIC EFFECT

[I] - Instruction on medical use approved by the Pharmacological Committee of the Ministry of Health of the Russian Federation

Antitussive, has analgesic, antiseptic and mildly local anesthetic effect.
Eliminates the unproductive irritating cough, with resorption creates a feeling of coolness in the mouth and throat. Does not exert a drying effect on the mucous membranes, does not cause a feeling of numbness in the mouth.
INDICATIONS

- inflammatory diseases of the respiratory tract (tonsillitis, pharyngitis, laryngitis);

- inflammatory diseases of the oral cavity (gingivitis, stomatitis);

- reflex cough (unproductive, irritating);

- preparation for instrumental studies of the oral cavity and throat, the removal of casts and fitting of dentures.

DOSING MODE

Inside, 25-50 mg 3-5 times / day (not more than 10), without chewing, keep in the mouth until it resorbs.

SIDE EFFECT

Individual intolerance is possible .

CONTRAINDICATIONS

hypersensitivity to the components of the drug;

- Pregnancy;

lactation period.

PREGNANCY AND LACTATION

In connection with the lack of sufficient experience in the use of this drug during pregnancy and during breast-feeding, use of Falimint ® at this time is not recommended.

SPECIAL INSTRUCTIONS

Do not use for prolonged use.
Immediately after use, refrain from eating food and liquids.
Patients with diabetes should take into account the sugar content (1 dragee corresponds to 0.03 bread units).

DRUG INTERACTION

It is still not known.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

List B.

At a temperature of no higher than 25 ° C, in a place protected from light.

Shelf life - 5 years.

The expiration date is indicated on the folding carton and on the primary packaging.

After the expiration of this period, the drug can not be used.

Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!